{"Q": 1, "answer": "no", "rationale": "The segment discusses manufacturing capacity but does not contain an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_20876", "batch_size": 200, "batch_pos": 103, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment is a neutral statement about manufacturing capacity.", "method": "llm_batch", "batch_id": "batch_2_6304", "batch_size": 200, "batch_pos": 69, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The verbs used are not moderate verbs from the approved list.", "method": "llm_batch", "batch_id": "batch_3_1476", "batch_size": 200, "batch_pos": 198, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_21272", "batch_size": 200, "batch_pos": 190, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports uncertainty about manufacturing numbers without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_20912", "batch_size": 200, "batch_pos": 187, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15352", "batch_size": 200, "batch_pos": 146, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment contains 'too early to tell', which is not a bare negation in the Q7 sense.", "method": "llm_batch", "batch_id": "batch_7_18664", "batch_size": 200, "batch_pos": 134, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "The segment states 'too early to tell how many doses Moderna will be able to manufacture', describing a limitation in manufacturing capability without explicit calming keywords.", "method": "llm_batch", "batch_id": "batch_8_21488", "batch_size": 200, "batch_pos": 136, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
